Are you a UK healthcare professional?

Yes No

GORD Management Today: Optimising the use of PPIs and alginates in clinical practice

Tuesday, October 6, 2026, 12:00 PM - 1:00 PM

Register
Agenda

This promotional webinar has been organised and funded by Reckitt Benckiser and is intended for UK healthcare professionals only. 

Tuesday, October 6, 2026

About this webinar

Register
Agenda

Join us on Tuesday, October 6, 2026 for a webinar exploring the current landscape of protein pump inhibitor prescriptions in the UK and the alternative options available to clinicians in line with current NICE guidelines. 

Designed specifically for GPs and Gastroenterologists, and delivered by two esteemed clinical experts, this webinar will discuss treatment options and their mechanisms of actions for GORD and heartburn as well as exploring alternative therapies to long-term PPI use.

Powered by

Why attend?

  • Understand the differences between GORD, Heartburn and Acid Reflux
  • Explore available treatment options for gastro-oesophageal reflux disease and heartburn/acid reflux, their mechanisms of action, and side effect profiles
  • Discuss therapy options from lifestyle to surgery and how to select the appropriate therapy for your patients
  • Feel confident in understanding and implementing current NICE guidelines including providing appropriate lifestyle advice, PPI prescription, duration and review
  • Discuss the benefits of recommended alternative therapies including alginate therapy 

Speakers

Professor Sir Pali Hungin
Professor Sir Pali Hungin
Professor Emeritus in the Faculty of Medical Sciences at Newcastle University
Dr Mark Follows
Dr Mark Follows
GPwER Gastroenterology in Norfolk

Agenda

Time Topic

12:00 - 12:05

Welcome and introduction
Chair: Professor Sir Pali Hungin, Professor Emeritus in the Faculty of Medical Sciences at Newcastle University

12:05 - 12:15

Reflux-like symptoms: the extent of PPI use and associated risks of long-term use
Professor Sir Pali Hungin, Professor Emeritus in the Faculty of Medical Sciences at Newcastle University

12:15 - 12:20

Potential side effects and adverse effects of PPIs
Dr Mark Follows, GPwER Gastroenterology

12:20 - 12:30

The causes of reflux like symptoms
Professor Sir Pali Hungin, Professor Emeritus in the Faculty of Medical Sciences at Newcastle University
Dr Mark Follows, GPwER Gasteroenterology

12:30 - 12:45

Strategies for reducing PPI use
Professor Sir Pali Hungin, Professor Emeritus in the Faculty of Medical Sciences at Newcastle University
Dr Mark Follows, GPwER Gasteroenterology

12:45 - 13:00

Q&A and summary
Professor Sir Pali Hungin, Professor Emeritus in the Faculty of Medical Sciences at Newcastle University
Dr Mark Follows, GPwER Gasteroenterology
Register
Agenda

Joining instructions

1

Ensure that you have registered for the event

2

On the morning of the webinar you will receive a link to login

3

If you haven't received an email link, click login on this website and reset your password if needed

4

Click 'WATCH LIVE' at the top of this website. You should automatically find yourself joining the webinar

5

Sit back and enjoy

About the Sponsor

Fast, effective relief with a proven safety profile1-3 

  • Resolves breakthrough symptoms and night reflux2

  • Provides effective interim relief when stopping or reducing proton pump inhibitor (PPI) dosage3

  • Gaviscon Advance forms a 53% stronger raft versus Peptac*4

  • Gaviscon Advance contains almost 60% less sodium than Gaviscon Original, Peptac and Acidex#1,5-7

*Compared with Algicon®, Gastrocote, Gaviscon Liquid, Gaviscon Regular Strength (USA), Gaviscon Extra Strength (USA), Mylanta® Heartburn Relief, Peptac and Rennie® Duo.
#Alginates commonly available on GORD formularies, calculations based on maximum daily dosage of each product. PPI, proton pump inhibitor.
 

References

1. Gaviscon Advance Aniseed flavour Oral Suspension. Summary of Product Characteristics. https://www.medicines.org.uk/emc/product/681/smpc. Accessed July 2026.
2. Reimer C et al. Aliment Pharmacol Ther. 2016;43:899–909.
3. Vales A et al. BMJ Open Gastro. 2023;10:e001026. 
4. Hampson FC et al. Int J Pharm. 2005;294:137–147.
5. Peptac Peppermint Liquid. Summary of Product Characteristics. https://www.medicines.org.uk/emc/product/15318/smpc. Accessed June 2026.
6. Gaviscon Original Aniseed Relief. Summary of Product Characteristics. https://www.medicines.org.uk/emc/product/623/smpc. Accessed July 2026.
7. Acidex Oral Suspension (PL 04917/0027). Summary of Product Characteristics. https://www.medicines.org.uk/emc/product/8799/smpc. Accessed July 2026.

If you have any questions about the event, please reach out to the team at events@cogora.com who are responsible for the logistics of this meeting.